Oxidative stress in obstructive sleep apnea: Putative pathways to the cardiovascular complications

Antioxidants and Redox Signaling

Volumn 10, Issue 4, 2008, Pages 755-768

  Yamauchi, Motoo ^a   Kimura, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRIDOXINE; REACTIVE OXYGEN METABOLITE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIET; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPOXIA; INFLAMMATION; METABOLIC DISORDER; NONHUMAN; OXIDATIVE STRESS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; SLEEP PARAMETERS;

ANIMALS; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; CHEMOKINES; HUMANS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; SLEEP APNEA, OBSTRUCTIVE;

EID: 38949134571     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1946     Document Type: Review

References (145)

1. Aldrich MS. Automobile accidents in patients with sleep disorders. Sleep 12: 487-494, 1989.
2. Altin R, Ozdemir H, Mahmutyazicioglu K, Kart L, Uzun L, Ozer T, Savranlar A, and Aydin M. Evaluation of carotid artery wall thickness with high-resolution sonography in obstructive sleep apnea syndrome. J Clin Ultrasound 33: 80-86, 2005.
3. Babu AR, Herdegen J, Fogelfeld L, Shott S, and Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 165: 447-452, 2005.
4. Baguet JP, Hammer L, Levy P, Pierre H, Launois S, Mallion JM, and Pepin JL. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 128: 3407-3412, 2005.
5. Baldwin CM, Bootzin RR, Schwenke DC, and Quan SF. Antioxidant nutrient intake and supplements as potential moderators of cognitive decline and cardiovascular disease in obstructive sleep apnea. Sleep Med Rev 9: 459-476, 2005.
6. Barbe F, Pericas J, Munoz A, Findley L, Anto JM, and Agusti AG. Automobile accidents in patients with sleep apnea syndrome: an epidemiological and mechanistic study. Am J Respir Crit Care Med 158: 18-22, 1998.
7. Barcelo A, Barbe F, de la Pena M, Vila M, Perez G, Pierola J, Duran J, and Agusti AG. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27: 756-760, 2006.
8. Barcelo A, Elorza MA, Barbe F, Santos C, Mayoralas LR, and Agusti AG. Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms. Eur Respir J 17: 728-732, 2001.
9. Barcelo A, Miralles C, Barbe F, Vila M, Pons S, and Agusti AG. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16: 644-647, 2000.
10. Barnes PJ and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.
11. Blake GJ and Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 41: 37S-42S, 2003.
12. Blake GJ, Rifai N, Buring JE, and Ridker PM. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 108: 2993-2999, 2003.
13. Campen MJ, Shimoda LA, and O'Donnell CP. Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice. J Appl Physiol 99: 2028-2035, 2005.
14. Can M, Acikgoz S, Mungan G, Bayraktaroglu T, Kocak E, Guven B, and Demirtas S. Serum cardiovascular risk factors in obstructive sleep apnea. Chest 129: 233-237, 2006.
15. Carlson JT, Rangemark C, and Hedner JA. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 14: 577-584, 1996.
16. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, and Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124: 1386-1392, 2003.
17. Chen L, Einbinder E, Zhang Q, Hasday J, Balke CW, and Scharf SM. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 172: 915-920, 2005.
18. Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T, Miyasaka M, and Ohi M. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109: 562-567, 2000.
19. Chin K, Nakamura T, Takahashi K, Sumi K, Matsumoto H, Niimi A, Fukuhara S, Mishima M, and Nakamura T. Falls in blood pressure in patients with obstructive sleep apnoea after long-term nasal continuous positive airway pressure treatment. J Hypertens 24: 2091-2099, 2006.
20. Christou K, Markoulis N, Moulas AN, Pastaka C, and Gourgoulianis KI. Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 7: 105-110, 2003.
21. Christou K, Moulas AN, Pastaka C, and Gourgoulianis KI. Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 4: 225-228, 2003.
22. Dhillon S, Chung SA, Fargher T, Huterer N, and Shapiro CM. Sleep apnea, hypertension, and the effects of continuous positive airway pressure. Am J Hypertens 18: 594-600, 2005.
23. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, and Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172: 613-618, 2005.
24. Dyken ME, Somers VK, Yamada T, Ren ZY, and Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 27: 401-407, 1996.
25. Dyugovskaya L, Lavie P, and Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165: 934-939, 2002.
26. El Solh AA, Saliba R, Bosinski T, Grant BJ, Berbary E, and Miller N. Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 27: 997-1002, 2006.
27. Fletcher AE, Breeze E, and Shetty PS. Antioxidant vitamins and mortality in older persons: findings from the nutrition add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Am J Clin Nutr 78: 999-1010, 2003.
28. Gjorup PH, Sadauskiene L, Wessels J, Nyvad O, Strunge B, and Pedersen EB. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 20: 44-52, 2007.
29. Glass CK and Witztum JL. Atherosclerosis. the road ahead. Cell 104: 503-516, 2001.
30. Grebe M, Eisele HJ, Weissmann N, Schaefer C, Tillmanns H, Seeger W, and Schulz R. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 173: 897-901, 2006.
31. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, and Liu SF. Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343: 591-596, 2006.
32. Guilleminault C, Kirisoglu C, and Ohayon MM. C-reactive protein and sleep-disordered breathing. Sleep 27: 1507-1511, 2004.
33. Haidara MA, Yassin HZ, Rateb M, Ammar H, and Zorkani MA. Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. Curr Vasc Pharmacol 4: 215-227, 2006.
34. Halliwell B. Antioxidants in human health and disease. Annu Rev Nutr 16: 33-50, 1996.
35. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695, 2005.
36. Hayashi M, Fujimoto K, Urushibata K, Takamizawa A, Kinoshita O, and Kubo K. Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome. Respirology 11: 24-31, 2006.
37. He K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC, and Ascherio A. Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 35: 169-174, 2004.
38. Hirota K and Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 59: 15-26, 2006.
39. Htoo AK, Greenberg H, Tongia S, Chen G, Henderson T, Wilson D, and Liu SF. Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath 10: 43-50, 2006.
40. Iiyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O'Doherty RM, Polotsky VY, and O'Donnell CP. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 175: 851-857, 2007.
41. Imagawa S, Yamaguchi Y, Higuchi M, Neichi T, Hasegawa Y, Mukai HY, Suzuki N, Yamamoto M, and Nagasawa T. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 98: 1255-1257, 2001.
42. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, and Lam WK. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162: 2166-2171, 2000.
43. Ip MS, Lam B, Lauder IJ, Tsang KW, Chung KF, Mok YW, and Lam WK. A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest 119: 62-69, 2001.
44. Ip MS, Tse HF, Lam B, Tsang KW, and Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169: 348-353, 2004.
45. Jordan W, Berger C, Cohrs S, Rodenbeck A, Mayer G, Niedmann PD, von Ahsen N, Ruther E, Kornhuber J, and Bleich S. CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. J Neural Transm 111: 683-689, 2004.
46. Joyeux-Faure M, Stanke-Labesque F, Lefebvre B, Beguin P, Godin-Ribuot D, Ribuot C, Launois SH, Bessard G, and Levy P. Chronic intermittent hypoxia increases infarction in the isolated rat heart. J Appl Physiol 98: 1691-1696, 2005.
47. Kaditis AG, Alexopoulos EI, Kalampouka E, Kostadima E, Germenis A, Zintzaras E, and Gourgoulianis K. Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 171: 282-286, 2005.
48. Kaneto H, Katakami N, Kawamori D, Miyatsuka T, Sakamoto K, Matsuoka TA, Matsuhisa M, and Yamasaki Y. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal 9: 355-366, 2007.
49. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, and Somers VK. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102: 2607-2610, 2000.
50. Knekt P, Ritz J, Pereira MA, O'Reilly EJ, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, Hallmans G, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Rimm EB, and Ascherio A. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 80: 1508-1520, 2004.
51. Kobayashi K, Nishimura Y, Shimada T, Yoshimura S, Funada Y, Satouchi M, and Yokoyama M. Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome. Chest 129: 632-637, 2006.
52. Kokturk O, Ciftci TU, Mollarecep E, and Ciftci B. Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome. Respir Med 100: 536-541, 2006.
53. Larkin EK, Rosen CL, Kirchner HL, Storfer-Isser A, Emancipator JL, Johnson NL, Zambito AM, Tracy RP, Jenny NS, and Redline S. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 111: 1978-1984, 2005.
54. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 7: 35-51, 2003.
55. Lavie L, Hefetz A, Luboshitzky R, and Lavie P. Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment. J Mol Neurosci 21: 57-63, 2003.
56. Lavie L, Kraiczi H, Hefetz A, Ghandour H, Perelman A, Hedner J, and Lavie P. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165: 1624-1628, 2002.
57. Lavie L, Vishnevsky A, and Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27: 123-128, 2004.
58. Lavie P, Herer P, and Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. Br Med J 320: 479-482, 2000.
59. Leung RS and Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 164: 2147-2165, 2001.
60. Li J, Savransky V, Nanayakkara A, Smith PL, O'Donnell CP, and Polotsky VY. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 102: 557-563, 2007.
61. Li J, Thorne LN, Punjabi NM, Sun CK, Schwartz AR, Smith PL, Marino RL, Rodriguez A, Hubbard WC, O'Donnell CP, and Polotsky VY. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97: 698-706, 2005.
62. Libby P, Ridker PM, and Maseri A. Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002.
63. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, and Semenza GL. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105: 659-669, 2005.
64. Marin JM, Carrizo SJ, Vicente E, and Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365: 1046-1053, 2005.
65. Martino F, Pignatelli P, Martino E, Morrone F, Carnevale R, Di Santo S, Buchetti B, Loffredo L, and Violi F. Early increase of oxidative stress and soluble CD40L in children with hypercholesterolemia. J Am Coll Cardiol 49: 1974-1981, 2007.
66. Masa JF, Rubio M, and Findley LJ. Habitually sleepy drivers have a high frequency of automobile crashes associated with respiratory disorders during sleep. Am J Respir Crit Care Med 162: 1407-1412, 2000.
67. McNicholas WT and Bonsigore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29: 156-178, 2007.
68. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, Sahadevan J, and Redline S. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 173: 910-916, 2006.
69. Mehta JL, Rasouli N, Sinha AK, and Molavi B. Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int J Biochem Cell Biol 38: 794-803, 2006.
70. Minoguchi K, Tazaki T, Yokoe T, Minoguchi H, Watanabe Y, Yamamoto M, and Adachi M. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 126: 1473-1479, 2004.
71. Minoguchi K, Yokoe T, Tanaka A, Ohta S, Hirano T, Yoshino G, O'Donnell CP, and Adachi M. Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respir J 28: 378-385, 2006.
72. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N, Okada S, Ohta S, Naito H, and Adachi M. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172: 625-630, 2005.
73. Moat SJ, Lang D, McDowell IF, Clarke ZL, Madhavan AK, Lewis MJ, and Goodfellow J. Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem 15: 64-79, 2004.
74. Moller DS, Lind P, Strunge B, and Pedersen EB. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 16: 274-280, 2003.
75. Nieto FJ, Herrington DM, Redline S, Benjamin EJ, and Robbins JA. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169: 354-360, 2004.
76. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, and Pickering TG. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 283: 1829-1836, 2000.
77. Ohara Y, Peterson TE, and Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91: 2546-2551, 1993.
78. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, and Ouchi Y. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87: 10-14, 1999.
79. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, and Ouchi Y. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94: 179-184, 2003.
80. Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Hu FB, Manson JE, and Willett WC. Vitamin C and risk of coronary heart disease in women. J Am Coll Cardiol 42: 246-252, 2003.
81. Ozturk L, Mansour B, Yuksel M, Yalcin AS, Celikoglu F, and Gokhan N. Lipid peroxidation and osmotic fragility of red blood cells in sleep-apnea patients. Clin Chim Acta 332: 83-88, 2003.
82. Pasceri V, Cheng JS, Willerson JT, and Yeh ET. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103: 2531-2534, 2001.
83. Pasceri V, Willerson JT, and Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165-2168, 2000.
84. Peker Y, Hedner J, Kraiczi H, and Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162: 81-86, 2000.
85. Peker Y, Kraiczi H, Hedner J, Loth S, Johansson A, and Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 14: 179-184, 1999.
86. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL, and Prabhakar NR. Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 577: 705-716, 2006.
87. Peppard PE, Young T, Palta M, and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342: 1378-1384, 2000.
88. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, and Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17: 61-66, 1999.
89. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103: 1813-1818, 2001.
90. Ridker PM, Hennekens CH, Buring JE, and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843, 2000.
91. Ridker PM, Rifai N, Rose L, Buring JE, and Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565, 2002.
92. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-126, 1999.
93. Row BW, Liu R, Xu W, Kheirandish L, and Gozal D. Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am J Respir Crit Care Med 167: 1548-1553, 2003.
94. Ryan CM, Usui K, Floras JS, and Bradley TD. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 60: 781-785, 2005.
95. Ryan S, Nolan G, Hannigan E, Cunningham S, Taylor CT, and McNicholas WT. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62: 509-514, 2007.
96. Ryan S, Taylor CT, and McNicholas WT. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 174: 824-830, 2006.
97. Ryan S, Taylor CT, and McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112: 2660-2667, 2005.
98. Saarelainen S, Seppala E, Laasonen K, and Hasan J. Circulating endothelin-1 in obstructive sleep apnea. Endothelium 5: 115-118, 1997.
99. Sajkov D, Cowie RJ, Thornton AT, Espinoza HA, and McEvoy RD. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 149: 416-422, 1994.
100. Sanguigni V, Ferro D, Pignatelli P, Del Ben M, Nadia T, Saliola M, Sorge R, and Violi F. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol 45: 35-42, 2005.
101. Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, and Luderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 92: 79-84, 1999.
102. Schulz R, Hummel C, Heinemann S, Seeger W, and Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 165: 67-70, 2002.
103. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, and Grimminger F. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162: 566-570, 2000.
104. Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lucke C, Mayer K, Olschewski H, Seeger W, and Grimminger F. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 55: 1046-1051, 2000.
105. Schulz R, Seeger W, Fegbeutel C, Husken H, Bodeker RH, Tillmanns H, and Grebe M. Changes in extracranial arteries in obstructive sleep apnoea. Eur Respir J 25: 69-74, 2005.
106. Semenza GL. Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res 1: 159-162, 2000.
107. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, and Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 290: 2945-2951, 2003.
108. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, and Somers VK. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105: 2462-2464, 2002.
109. Simon JA, Murtaugh MA, Gross MD, Loria CM, Hulley SB, and Jacobs DR Jr. Relation of ascorbic acid to coronary artery calcium: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 159: 581-588, 2004.
110. Smith R, Ronald J, Delaive K, Walld R, Manfreda J, and Kryger MH. What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest 121: 164-172, 2002.
111. Sullivan CE, Issa FG, Berthon-Jones M, and Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1: 862-865, 1981.
112. Suzuki T, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Yamauchi M, and Kimura H. Obstructive sleep apnea and carotidartery intima-media thickness. Sleep 27: 129-133, 2004.
113. Suzuki YJ, Jain V, Park AM, and Day RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 40: 1683-1692, 2006.
114. Svatikova A, Wolk R, Lerman LO, Juncos LA, Greene EL, McConnell JP, and Somers VK. Oxidative stress in obstructive sleep apnoea. Eur Heart J 26: 2435-2439, 2005.
115. Svatikova A, Wolk R, Magera MJ, Shamsuzzaman AS, Phillips BG, and Somers VK. Plasma homocysteine in obstructive sleep apnoea. Eur Heart J 25: 1325-1329, 2004.
116. Takahashi S, Nakamura Y, Nishijima T, Sakurai S, and Inoue H. Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome. Respir Med 99: 1125-1131, 2005.
117. Tanriverdi H, Evrengul H, Kara CO, Kuru O, Tanriverdi S, Ozkurt S, Kaftan A, and Kilic M. Aortic stiffness, flow-mediated dilatation and carotid intima-media thickness in obstructive sleep apnea: non-invasive indicators of atherosclerosis. Respiration 73: 741-750, 2006.
118. Tarasiuk A, Greenberg-Dotan S, Brin YS, Simon T, Tal A, and Reuveni H. Determinants affecting health-care utilization in obstructive sleep apnea syndrome patients. Chest 128: 1310-1314, 2005.
119. Tauman R, Ivanenko A, O'Brien LM, and Gozal D. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 113: e564-e569, 2004.
120. Tazaki T, Minoguchi K, Yokoe T, Samson KT, Minoguchi H, Tanaka A, Watanabe Y, and Adachi M. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 170: 1354-1359, 2004.
121. Teramoto S, Kume H, Matsuse T, Ishii T, Miyashita A, Akishita M, Toba K, and Ouchi Y. Oxygen administration improves the serum level of nitric oxide metabolites in patients with obstructive sleep apnea syndrome. Sleep Med 4: 403-407, 2003.
122. Teran-Santos J, Jimenez-Gomez A, and Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents: Cooperative Group Burgos-Santander. N Engl J Med 340: 847-851, 1999.
123. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, and Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291: 565-575, 2004.
124. Veasey SC, Davis CW, Fenik P, Zhan G, Hsu YJ, Pratico D, and Gow A. Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep 27: 194-201, 2004.
125. Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, and Mickle DA. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105: 1890-1896, 2002.
126. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, and Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82: 1313-1316, 1997.
127. Vogel RA. Heads and hearts: the endothelial connection. Circulation 107: 2766-2768, 2003.
128. Voko Z, Hollander M, Hofman A, Koudstaal PJ, and Breteler MM. Dietary antioxidants and the risk of ischemic stroke: the Rotterdam Study. Neurology 61: 1273-1275, 2003.
129. Wali SO, Bahammam AS, Massaeli H, Pierce GN, Iliskovic N, Singal PK, and Kryger MH. Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep 21: 290-296, 1998.
130. Wittmann V and Rodenstein DO. Health care costs and the sleep apnea syndrome. Sleep Med Rev 8: 269-279, 2004.
131. Wright E Jr, Scism-Bacon JL, and Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 60: 308-314, 2006.
132. Xu W, Chi L, Row BW, Xu R, Ke Y, Xu B, Luo C, Kheirandish L, Gozal D, and Liu R. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 126: 313-323, 2004.
133. Yaggi H and Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol 3: 333-342, 2004.
134. Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, and Kimura H. Oxidative stress in obstructive sleep apnea. Chest 127: 1674-1679, 2005.
135. Yamauchi M, Tamaki S, Tomoda K, Yoshikawa M, Fukuoka A, Makinodan K, Koyama N, Suzuki T, and Kimura H. Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep Breath 10: 189-193, 2006.
136. Yao M, Tachibana N, Okura M, Ikeda A, Tanigawa T, Yamagishi K, Sato S, Shimamoto T, and Iso H. The relationship between sleep-disordered breathing and high-sensitivity C-reactive protein in Japanese men. Sleep 29: 661-665, 2006.
137. Yeh ET, Anderson HV, Pasceri V, and Willerson JT. C-reactive protein: linking inflammation to cardiovascular complications. Circulation 104: 974-975, 2001.
138. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, and Adachi M. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107: 1129-1134, 2003.
139. Young T, Blustein J, Finn L, and Palta M. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 20: 608-613, 1997.
140. Young T, Palta M, Dempsey J, Skatrud J, Weber S, and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328: 1230-1235, 1993.
141. Yuan G, Nanduri J, Bhasker CR, Semenza GL, and Prabhakar NR. Ca2+-/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem 280: 4321-4328, 2005.
142. Zhan G, Serrano F, Fenik P, Hsu R, Kong L, Pratico D, Klann E, and Veasey SC. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 172: 921-929, 2005.
143. Zouaoui Boudjeltia K, Van Meerhaeghe A, Doumit S, Guillaume M, Cauchie P, Brohee D, Vanhaeverbeek M, and Kerkhofs M. Sleep apnoea-hypopnoea index is an independent predictor of high-sensitivity C-reactive protein elevation. Respiration 73: 243-246, 2006.
144. Zozula R and Rosen R. Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes. Curr Opin Pulm Med 7: 391-398, 2001.
145. Zwaka TP, Hombach V, and Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 103: 1194-1197, 2001.